beta
/Inhalable Rapamycin Formulation For The Treatment Of Pulmonary Hypertension
Abstract

The present invention relates to methods and compositions for the treatment and prophylaxis of pulmonary arterial hypertension (PAH) in a human subject in need of such treatment, the methods comprising the pulmonary administration to the subject, preferably via inhalation of a composition comprising rapamycin or a prodrug or derivative thereof.

Full Text

What is claimed is:

The present invention relates to methods and compositions for the treatment and prophylaxis of pulmonary arterial hypertension (PAH) in a human subject in need of such treatment, the methods comprising the pulmonary administration to the subject, preferably via inhalation of a composition comprising rapamycin or a prodrug or derivative thereof.
Timeline
Filed
03/12/2026
Published
07/16/2026
Granted
Not Available
IPC Codes(6)
A61K 31/436:the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 9/12:Aerosols; Foams